Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mediastinal large B-cell lymphoma].

T F E Barth1, P Möller

  • 1Institut für Pathologie, Universität Ulm.

Der Pathologe
|December 30, 2006
PubMed
Summary
This summary is machine-generated.

Mediastinal B-cell lymphoma, a rare and aggressive tumor, is now recognized as a distinct entity. It has unique features leading to its classification as a separate disease code.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diffuse pulmonary ossifications with mortal consequences. A case report].

Der Pathologe·2003
Same author

CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts.

Virchows Archiv : an international journal of pathology·2003
Same author

Anthropogenic Gd in surface water, drainage system, and the water supply of the city of Prague, Czech Republic.

Environmental science & technology·2002
Same author

Comparison of adhesion of the food spoilage bacterium Shewanella putrefaciens to stainless steel and silver surfaces.

Journal of applied microbiology·2002
Same author

[Information to families with hereditary breast and ovarian cancer].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2002
Same author

Mediastinal B-cell lymphoma, a lymphoma type with several characteristics unique among diffuse large B-cell lymphomas.

Annals of hematology·2002
Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022
Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022
Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022
Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022
Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022
Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022
See all related articles

Area of Science:

  • Oncology
  • Hematology
  • Pathology

Context:

  • Mediastinal B-cell lymphoma (MBCL) is a rare, aggressive tumor first described in the early 1980s.
  • It accounts for 2-3% of all non-Hodgkin's lymphomas.
  • Its classification has been challenging due to low incidence and morphological diversity.

Purpose:

  • To detail the distinct characteristics of mediastinal B-cell lymphoma.
  • To highlight its evolving classification within lymphoid neoplasms.
  • To establish its recognition as a unique disease entity.

Summary:

  • MBCL exhibits distinct morphological, immunological, genetic, and clinical features.
  • It was incorporated into the REAL Classification in 1994 as a variant of diffuse large B-cell lymphoma.

Related Experiment Videos

  • Currently, the World Health Organization classification recognizes MBCL with its own disease code (ICD-9679/3).

    • Impact:

    • MBCL is now recognized as a distinct disease entity with its own ICD code.
    • This improved classification aids in diagnosis and treatment strategies.
    • Enhanced understanding facilitates further research into this specific lymphoma subtype.